Triple Agonist 14mg — Verification Report
From Sunrise BioResearch · Lot GLP3140426 · Tested April 2026
VialTalk
Triple Agonist 14mg
Sunrise BioResearch
Score
105.5
Grade
A++
Superlative
Lot GLP3140426
Tested April 2026
Report ID
7f39b820
Test
Method
Result
Status
PurityFull credit
HPLC
99.5%
Full credit
IdentityFull credit
Mass spectrometry
Confirmed
Full credit
ContentStrong
Gravimetric vs label claim
14 mg labeled · 14.63 mg tested
Strong
EndotoxinFull credit
USP <85> compendial
Screened
Full credit
Heavy metalsFull credit
USP <232>/<233> compendial
Screened
Full credit
SterilityFull credit
USP <71> compendial
Screened
Full credit
Batch conformityPartial
Two-plus vials, per vial
Assessed
Partial
Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.
This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →
Canonical source: https://vialtalk.com/vendors/sunrise-bioresearch/coas/7f39b820-f8cc-469c-b21c-90c419fab427